U.S. Manufacturers Still Favor Three Batches in Process Validation
This article was originally published in The Gold Sheet
Executive Summary
Despite FDA’s prodding to focus on the science and not the numbers, the pharmaceutical industry still favors a three-batch approach to process validation.